Synthetic Drugs in East and Southeast Asia. Latest developments and challenges

Synthetic Drugs in East and Southeast Asia. Latest developments and challenges
reply

As of December 2020, a total of 485 different NPS have been identified in East and Southeast Asia. Though the number of newly identified NPS each year in the region has continued to decline since 2015, this may, in part, be due to the limited forensic capacity of some countries in the region to identify these substances.

Synthetic cannabinoids dominate the regional NPS market in East and Southeast Asia. China, Indonesia, Malaysia, Singapore, the Republic of Korea, and Viet Nam reported that synthetic cannabinoids were the most identified NPS in samples analysed. The Republic of Korea and Indonesia also reported increases in the amount of synthetic cannabinoids seized in 2020 compared to 2019.

Published in 2021 by UNODC